Skip to main content
. 2020 Jun 3;9(6):1392. doi: 10.3390/cells9061392

Figure 4.

Figure 4

Therapeutic modelling to reduce or inhibit the therapeutic resistance property of CSCs. (i) Inhibition of cell cycle checkpoints, (ii) Inhibition of hyper-activated signalling pathways, (iii) Regulated expression of miRNAs, (iv) Induction of differentiation of CSCs.